157 related articles for article (PubMed ID: 38690279)
1. Additional prognostic value of polymorphisms within the 3'-untranslated region of programmed cell death pathway genes in early-stage breast cancer.
Chen H; Chen M; Zeng B; Tang L; Nie Q; Jin X; Guo W; Chen L; Lin Y; Wang C; Fu F
Front Immunol; 2024; 15():1284579. PubMed ID: 38690279
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms of ESR1, UGT1A1, HCN1, MAP3K1 and CYP2B6 are associated with the prognosis of hormone receptor-positive early breast cancer.
Kuo SH; Yang SY; You SL; Lien HC; Lin CH; Lin PH; Huang CS
Oncotarget; 2017 Mar; 8(13):20925-20938. PubMed ID: 28178648
[TBL] [Abstract][Full Text] [Related]
3. The influence of functional polymorphisms in matrix metalloproteinase 9 on survival of breast cancer patients in a Chinese population.
Fu F; Wang C; Chen LM; Huang M; Huang HG
DNA Cell Biol; 2013 May; 32(5):274-82. PubMed ID: 23570558
[TBL] [Abstract][Full Text] [Related]
4. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy.
Lei J; Rudolph A; Moysich KB; Rafiq S; Behrens S; Goode EL; Pharoah PP; Seibold P; Fasching PA; Andrulis IL; Kristensen VN; Couch FJ; Hamann U; Hooning MJ; Nevanlinna H; Eilber U; Bolla MK; Dennis J; Wang Q; Lindblom A; Mannermaa A; Lambrechts D; García-Closas M; Hall P; Chenevix-Trench G; Shah M; Luben R; Haeberle L; Ekici AB; Beckmann MW; Knight JA; Glendon G; Tchatchou S; Alnæs GI; Borresen-Dale AL; Nord S; Olson JE; Hallberg E; Vachon C; Torres D; Ulmer HU; Rüdiger T; Jager A; van Deurzen CH; Tilanus-Linthorst MM; Muranen TA; Aittomäki K; Blomqvist C; Margolin S; Kosma VM; Hartikainen JM; Kataja V; Hatse S; Wildiers H; Smeets A; Figueroa J; Chanock SJ; Lissowska J; Li J; Humphreys K; Phillips KA; ; Linn S; Cornelissen S; van den Broek SA; Kang D; Choi JY; Park SK; Yoo KY; Hsiung CN; Wu PE; Hou MF; Shen CY; Teo SH; Taib NA; Yip CH; Ho GF; Matsuo K; Ito H; Iwata H; Tajima K; Dunning AM; Benitez J; Czene K; Sucheston LE; Maishman T; Tapper WJ; Eccles D; Easton DF; Schmidt MK; Chang-Claude J
Breast Cancer Res; 2015 Feb; 17(1):18. PubMed ID: 25849327
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of IL10 and TNF alpha functional polymorphisms in premenopausal early-stage breast cancer patients.
Korobeinikova E; Myrzaliyeva D; Ugenskiene R; Raulinaityte D; Gedminaite J; Smigelskas K; Juozaityte E
BMC Genet; 2015 Jun; 16():70. PubMed ID: 26112140
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of genetic variants in microRNA biosynthesis genes and risk of breast cancer in Chinese women.
Jiang Y; Chen J; Wu J; Hu Z; Qin Z; Liu X; Guan X; Wang Y; Han J; Jiang T; Jin G; Zhang M; Ma H; Wang S; Shen H
Int J Cancer; 2013 Nov; 133(9):2216-24. PubMed ID: 23629745
[TBL] [Abstract][Full Text] [Related]
7. The relationship between eight GWAS-identified single-nucleotide polymorphisms and primary breast cancer outcomes.
Bayraktar S; Thompson PA; Yoo SY; Do KA; Sahin AA; Arun BK; Bondy ML; Brewster AM
Oncologist; 2013; 18(5):493-500. PubMed ID: 23635555
[TBL] [Abstract][Full Text] [Related]
8. Single nucleotide polymorphisms within MicroRNAs, MicroRNA targets, and MicroRNA biogenesis genes and their impact on colorectal cancer survival.
Mullany LE; Herrick JS; Wolff RK; Slattery ML
Genes Chromosomes Cancer; 2017 Apr; 56(4):285-295. PubMed ID: 27859935
[TBL] [Abstract][Full Text] [Related]
9. Single nucleotide polymorphisms of the aromatase gene (CYP19A1), HER2/neu status, and prognosis in breast cancer patients.
Fasching PA; Loehberg CR; Strissel PL; Lux MP; Bani MR; Schrauder M; Geiler S; Ringleff K; Oeser S; Weihbrecht S; Schulz-Wendtland R; Hartmann A; Beckmann MW; Strick R
Breast Cancer Res Treat; 2008 Nov; 112(1):89-98. PubMed ID: 18049890
[TBL] [Abstract][Full Text] [Related]
10. Role of XRCC3, XRCC1 and XPD single-nucleotide polymorphisms in survival outcomes following adjuvant chemotherapy in early stage breast cancer patients.
Castro E; Olmos D; Garcia A; Cruz JJ; González-Sarmiento R
Clin Transl Oncol; 2014 Feb; 16(2):158-65. PubMed ID: 23740134
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes.
Curtit E; Pivot X; Henriques J; Paget-Bailly S; Fumoleau P; Rios M; Bonnefoi H; Bachelot T; Soulié P; Jouannaud C; Bourgeois H; Petit T; Tennevet I; Assouline D; Mathieu MC; Jacquin JP; Lavau-Denes S; Darut-Jouve A; Ferrero JM; Tarpin C; Lévy C; Delecroix V; Trillet-Lenoir V; Cojocarasu O; Meunier J; Pierga JY; Kerbrat P; Faure-Mercier C; Blanché H; Sahbatou M; Boland A; Bacq D; Besse C; Thomas G; Deleuze JF; Pauporté I; Romieu G; Cox DG
Breast Cancer Res; 2017 Aug; 19(1):98. PubMed ID: 28830573
[TBL] [Abstract][Full Text] [Related]
12. Common genetic polymorphisms of microRNA biogenesis pathway genes and breast cancer survival.
Sung H; Jeon S; Lee KM; Han S; Song M; Choi JY; Park SK; Yoo KY; Noh DY; Ahn SH; Kang D
BMC Cancer; 2012 May; 12():195. PubMed ID: 22639842
[TBL] [Abstract][Full Text] [Related]
13. A genetic variant in p63 (rs17506395) is associated with breast cancer susceptibility and prognosis.
Zhang N; Huo Q; Wang X; Chen X; Long L; Guan X; Jiang L; Ma T; Hu W; Yang Q
Gene; 2014 Feb; 535(2):170-6. PubMed ID: 24316488
[TBL] [Abstract][Full Text] [Related]
14. Genetic variation in microRNA-binding site and prognosis of patients with colorectal cancer.
Kim JG; Chae YS; Lee SJ; Kang BW; Park JY; Lee EJ; Jeon HS; Park JS; Choi GS
J Cancer Res Clin Oncol; 2015 Jan; 141(1):35-41. PubMed ID: 25079514
[TBL] [Abstract][Full Text] [Related]
15. Subtype-specific associations between breast cancer risk polymorphisms and the survival of early-stage breast cancer.
Fu F; Guo W; Lin Y; Zeng B; Qiu W; Huang M; Wang C
J Transl Med; 2018 Oct; 16(1):270. PubMed ID: 30285756
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphism of miR-196a as a prognostic biomarker for early breast cancer.
Lee SJ; Seo JW; Chae YS; Kim JG; Kang BW; Kim WW; Jung JH; Park HY; Jeong JY; Park JY
Anticancer Res; 2014 Jun; 34(6):2943-9. PubMed ID: 24922658
[TBL] [Abstract][Full Text] [Related]
17. An miR-502-binding site single-nucleotide polymorphism in the 3'-untranslated region of the SET8 gene is associated with early age of breast cancer onset.
Song F; Zheng H; Liu B; Wei S; Dai H; Zhang L; Calin GA; Hao X; Wei Q; Zhang W; Chen K
Clin Cancer Res; 2009 Oct; 15(19):6292-300. PubMed ID: 19789321
[TBL] [Abstract][Full Text] [Related]
18. Tumor PIK3CA Genotype and Prognosis in Early-Stage Breast Cancer: A Pooled Analysis of Individual Patient Data.
Zardavas D; Te Marvelde L; Milne RL; Fumagalli D; Fountzilas G; Kotoula V; Razis E; Papaxoinis G; Joensuu H; Moynahan ME; Hennessy BT; Bieche I; Saal LH; Stal O; Iacopetta B; Jensen JD; O'Toole S; Lopez-Knowles E; Barbaraeschi M; Noguchi S; Azim HA; Lerma E; Bachelot T; Wang Q; Perez-Tenorio G; Can de Velde CJH; Rea DW; Sabine V; Bartlett JMS; Sotiriou C; Michiels S; Loi S
J Clin Oncol; 2018 Apr; 36(10):981-990. PubMed ID: 29470143
[TBL] [Abstract][Full Text] [Related]
19. Replication study for reported SNP associations with breast cancer survival.
Beeghly-Fadiel A; Zheng W; Lu W; Long J; Zheng Y; Cai H; Gu K; Chen Z; Cai Q; Gao YT; Shu XO
J Cancer Res Clin Oncol; 2012 Jun; 138(6):1019-26. PubMed ID: 22367361
[TBL] [Abstract][Full Text] [Related]
20. The associations of genetic polymorphisms in CYP1A2 and CYP3A4 with clinical outcomes of breast cancer patients in northern China.
Bai X; Xie J; Sun S; Zhang X; Jiang Y; Pang D
Oncotarget; 2017 Jun; 8(24):38367-38377. PubMed ID: 28418906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
